Edmond DE Rothschild Holding S.A. Has $1.35 Million Stock Holdings in Align Technology, Inc. $ALGN

Key Points

• Edmond DE Rothschild Holding S.A. reduced its position in Align Technology, Inc. by 66.2%, selling 16,703 shares and retaining 8,515 shares valued at approximately $1.35 million.
• Align Technology reported a quarterly earnings miss, with $2.49 earnings per share compared to analysts' expectations of $2.57, alongside a 1.6% year-over-year decline in revenue.
• The company's board has authorized a $200 million share buyback plan, indicating confidence in the stock's value amid fluctuations in price targets from various analysts.

Edmond DE Rothschild Holding S.A. reduced its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 66.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,515 shares of the medical equipment provider's stock after selling 16,703 shares during the quarter. Edmond DE Rothschild Holding S.A.'s holdings in Align Technology were worth $1,353,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Banque Transatlantique SA boosted its position in shares of Align Technology by 11,213.8% during the first quarter. Banque Transatlantique SA now owns 3,281 shares of the medical equipment provider's stock worth $482,000 after buying an additional 3,252 shares during the period. AQR Capital Management LLC boosted its position in Align Technology by 104.2% during the first quarter. AQR Capital Management LLC now owns 404,310 shares of the medical equipment provider's stock valued at $63,133,000 after purchasing an additional 206,308 shares during the last quarter. Adage Capital Partners GP L.L.C. boosted its position in Align Technology by 94.2% during the first quarter. Adage Capital Partners GP L.L.C. now owns 127,388 shares of the medical equipment provider's stock valued at $20,237,000 after purchasing an additional 61,788 shares during the last quarter. Bares Capital Management Inc. boosted its position in Align Technology by 4.8% during the first quarter. Bares Capital Management Inc. now owns 537,606 shares of the medical equipment provider's stock valued at $85,404,000 after purchasing an additional 24,481 shares during the last quarter. Finally, Perbak Capital Partners LLP bought a new stake in Align Technology in the first quarter valued at approximately $332,000. 88.43% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on ALGN. Morgan Stanley restated an "equal weight" rating and issued a $154.00 price objective (down previously from $249.00) on shares of Align Technology in a research note on Thursday, July 31st. Evercore ISI increased their target price on Align Technology from $200.00 to $220.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 9th. Mizuho set a $210.00 target price on Align Technology in a research note on Thursday, July 31st. Wells Fargo & Company lowered their target price on Align Technology from $246.00 to $199.00 and set an "overweight" rating on the stock in a research note on Thursday, July 31st. Finally, Stifel Nicolaus lowered their target price on Align Technology from $275.00 to $200.00 and set a "buy" rating on the stock in a research note on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Align Technology presently has an average rating of "Moderate Buy" and an average price target of $215.00.

Insider Buying and Selling at Align Technology

In other Align Technology news, CEO Joseph M. Hogan bought 7,576 shares of Align Technology stock in a transaction on Friday, August 1st. The shares were purchased at an average price of $131.49 per share, with a total value of $996,168.24. Following the acquisition, the chief executive officer owned 184,945 shares in the company, valued at $24,318,418.05. This trade represents a 4.27% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.66% of the company's stock.

Align Technology Price Performance

Align Technology stock traded down $2.26 during mid-day trading on Monday, reaching $136.86. 1,408,549 shares of the company were exchanged, compared to its average volume of 1,316,050. The company has a fifty day simple moving average of $165.60 and a 200-day simple moving average of $171.45. Align Technology, Inc. has a 12 month low of $127.70 and a 12 month high of $262.87. The firm has a market cap of $9.92 billion, a PE ratio of 23.08, a PEG ratio of 1.57 and a beta of 1.65.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing analysts' consensus estimates of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter last year, the business earned $2.41 EPS. Align Technology's revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its Board of Directors has authorized a share buyback plan on Tuesday, August 5th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.